As per MRFR analysis, the China Organ Preservation Market Size was estimated at 19.28 (USD Million) in 2023. The China Organ Preservation Market Industry is expected to grow from 20.4(USD Million) in 2024 to 37.2 (USD Million) by 2035. The China Organ Preservation Market CAGR (growth rate) is expected to be around 5.613% during the forecast period (2025 - 2035).
The China Organ Preservation Market is experiencing several key market trends driven by advancements in technology and an increasing demand for organ transplants. The government of China has been promoting organ donation and transplantation as part of its healthcare reforms. Recent initiatives to improve organ preservation techniques have led to a higher survival rate for organs during transplants.
This has resulted in increased interest from healthcare facilities to adopt better preservation solutions. Organizations in China are focusing on developing new preservation methodologies, which include hypothermic machine perfusion and the use of novel preservation solutions aimed at extending organ viability. Opportunities in the China Organ Preservation Market are abundant due to the growing need for effective organ storage solutions.
There is a notable rise in the aging population in China, leading to more instances of organ failure and the subsequent demand for transplants. As healthcare infrastructure continues to improve, especially in rural areas, there is potential for expanding organ preservation technologies to a wider demographic. Additionally, collaborations between academic institutions and medical technology companies present opportunities for innovation in preservation methods.
Trends in recent times reflect a shift towards personalized medicine and precision organ transplantation. With advancements in biopreservation technologies, the focus has been on developing tailored solutions that can cater to specific organ types and donor conditions. Furthermore, the emphasis on training healthcare professionals in organ preservation techniques is growing.
This is essential for ensuring that advancements lead to practical applications in hospitals and transplant centers across China, ultimately improving patient outcomes in organ transplantation.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
One major factor propelling the China Organ Preservation Market Industry is the rise in organ transplant procedures in China. According to China's National Health Commission, there are more than 300,000 people on the waiting list for organ transplants, which is driving up demand for preserved organs.
Organizations like the Red Cross Society of China, which promotes organ donation programs, have been instrumental in the recent shift in public understanding. As a result, organ donation rates have grown, and there is a greater need for preservation methods to keep these organs viable while being transported.
Furthermore, the need for sophisticated organ preservation techniques is highlighted by a noticeable rise in the number of kidney and liver transplants, which are among the most common operations. About 10,000 kidney transplants were carried out in 2019, and as awareness rises and preservation methods advance, this number is expected to rise. The need for effective organ preservation solutions is being further fueled by the growing medical infrastructure.
Continuous Research and Development (R&D) efforts in organ preservation technologies are shaping the future of the China Organ Preservation Market Industry. Notable advancements in preservation techniques, such as machine perfusion and novel cryopreservation methods, have increased organ viability outside the body.
Organizations like the Chinese Academy of Medical Sciences are pioneering innovations, with research demonstrating that machine perfusion can extend preservation time by up to 50%. This technological evolution is critical in addressing the growing number of transplant surgeries and managing the limited organ supply effectively.
By supporting improved transportation and longer storage times, these advancements are vital in bridging the gap between organ donation and transplantation needs.
Government policies and initiatives promoting organ donation in China are fundamental drivers for the China Organ Preservation Market Industry. The Chinese government has implemented several regulations encouraging organ donation, such as the establishment of a national organ donation system in 2010.
This system has seen a steady increase in donations, ascending from 4,000 in 2011 to nearly 38,000 in 2020. These initiatives not only enhance public awareness but also create an ecosystem where organ preservation becomes essential to support the growing number of donations.
Furthermore, factors like the recent spike in health concerns due to COVID-19 prompting a broader societal discussion on health and organ health awareness, it emphasizes the importance of efficient organ preservation strategies.
The China Organ Preservation Market related to Solutions holds a significant position in ensuring the viability of organs for transplantation. This segment encompasses various solutions tailored to meet the needs of preservation at different temperatures and durations, ensuring optimal conditions to maintain organ functionality.
University of Wisconsin Solution is widely recognized for its ability to prolong organ preservation times. Custodial HTK Solution offers a balanced formulation advantageous for liver and kidney preservation. Collins Solution is primarily used for cardiac preservation and has been pivotal in advancing cardiac transplantation success rates.
Further, the Celsior Solution is now gaining traction among physicians due to its favorable outcomes in heart and liver transplantation, reflecting the continuous evolution in preservation technology. Perfadex is particularly highlighted for its effectiveness in preserving lungs, which are delicate and require precise handling to prevent damage during transport.
Citrate Solution, often utilized in kidney preservation, adds another layer of efficiency, ensuring that the organs remain in a stable condition before transplantation. The growth of the China Organ Preservation Market is influenced by factors such as increasing organ donation rates, advancements in medical technology, and a growing healthcare network.
The importance of these solutions lies not only in their diverse applications but also in their ability to adapt to the specific requirements of each organ type, signifying their pivotal role in the broader context of organ transplantation and preservation. Additionally, the rising number of transplant procedures in China continues to drive demand for effective preservation solutions, thereby nurturing market growth.
As the nation's healthcare infrastructure develops and awareness of organ donation increases, the demand for reliable solutions is expected to rise, enhancing overall patient outcomes and saving lives. This growth trajectory underlines the crucial role the Solutions segment plays in the overall dynamics of the China Organ Preservation Market.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
The Preservation Techniques segment of the China Organ Preservation Market plays a critical role in ensuring the viability of organs for transplantation. This segment encompasses various methods, primarily Static Cold Storage and Dynamic Cold Storage, which contribute significantly to the overall efficiency of organ preservation.
Static Cold Storage remains a widely utilized technique due to its simplicity and effectiveness in maintaining organ viability in a controlled environment. Dynamic Cold Storage is increasingly gaining traction because it allows for more advanced preservation through continuous oxygenation and temperature control.
Dynamic Cold Storage enhances the organ's metabolic state during transportation. As the China Organ Preservation Market responds to growing transplantation demands driven by an aging population and rising incidences of organ failures, these preservation techniques are pivotal in improving donor organ availability and reducing waste.
Moreover, advancements in technology and increased investments in Research and Development within the healthcare sector are expected to propel the growth of this segment. The China government’s focus on enhancing healthcare infrastructure further supports the potential growth and innovation in this vital area, capturing a significant share of the organ preservation landscape in the country.
Overall, the Preservation Techniques segment remains integral to ensuring successful transplant outcomes, thereby addressing the critical needs of patients in China.
The China Organ Preservation Market is experiencing significant growth, driven by advancements in medical technology and rising awareness around organ donation and preservation methods. The Organ Type segment encompasses critical categories such as Kidney, Liver, Heart, and Lungs, each playing a vital role in transplantation and medical treatments.
The Kidney segment holds a major share due to the high demand for kidney transplants. The Liver segment is also crucial as liver diseases are prevalent. The Heart segment is important as cardiovascular diseases are a leading cause of mortality. The Lungs segment is vital given the increasing incidence of respiratory diseases.
Overall, the growing number of patients on transplant lists and the need for efficient preservation methods highlight the importance of these organ types in the China Organ Preservation Market. This reflects a broader trend toward improved healthcare practices and technologies across the nation.
The End User segment of the China Organ Preservation Market plays a critical role in the overall landscape of the industry, comprising various key players that facilitate organ preservation processes. Hospitals and Clinics represent a major portion of this segment, functioning as primary centers where organ transplantation procedures occur.
These institutions are equipped with advanced technologies for organ preservation. Organ Banks also significantly contribute to this market, acting as centralized repositories that manage and store donated organs before transplantation.
The importance of these banks is underscored by their systematic approach to matching donors with recipients, which is crucial for improving transplant success rates. Furthermore, trends in the China Organ Preservation Market indicate a growing collaboration between hospitals, clinics, and organ banks, emphasizing the importance of integrated healthcare solutions.
Challenges such as the need for standardized preservation protocols and efficient logistics persist, yet they also present opportunities for innovation in preservation techniques and technology within these facilities. Overall, the End User segment is essential for ensuring that the benefits of organ preservation translate into successful transplantation outcomes in China.
The China Organ Preservation Market is an evolving sector that has gained remarkable attention due to increasing organ transplant procedures and a growing demand for effective organ preservation techniques. In this competitive landscape, various companies are vying for market share by innovating preservation solutions and expanding their distribution networks.
Advancements in technology, a focus on improving transplant outcomes, and increased healthcare investments have spurred growth in this market. Moreover, the regulatory environment in China, emphasizing the importance of organ donation and transplantation, adds another layer of complexity to the competition.
Companies are pushing for better performance and efficiency in organ preservation solutions, leading to enhanced partnerships, research collaborations, and strategic expansions to solidify their market position.
Sinopharm has established a prominent presence in the China Organ Preservation Market by capitalizing on its extensive distribution network and strong government relationships. The company's strengths lie in its ability to integrate logistics and supply chain management to ensure efficient delivery of organ preservation products.
As one of the leading pharmaceutical firms in China, Sinopharm benefits from economies of scale, allowing it to offer competitive pricing and reliable services. Additionally, its commitment to research and development enables the company to stay ahead in innovation, particularly in the areas of low-temperature preservation and preservation solutions that extend organ viability.
With a reputation for reliability in the healthcare sector, Sinopharm has gained substantial trust and confidence from transplant centers and hospitals.
United Therapeutics Corporation operates with a specialized focus within the China Organ Preservation Market, particularly known for its innovative contributions to organ transplant technologies and preservation methods. The company has made significant inroads in the region through its advanced products and technologies aimed at improving organ viability and transplant outcomes.
United Therapeutics Corporation boasts a strong portfolio that includes key offerings tailored for organ preservation, leveraging novel techniques to enhance preservation times. The company has strategically positioned itself by securing collaborations and partnerships with local healthcare providers and research institutions.
Recent mergers and acquisitions further demonstrate its intent to enhance its market presence, effectively expanding its capabilities and access to cutting-edge preservation technology. United Therapeutics Corporation's focus on research translates into ongoing improvements in product offerings, reinforcing its commitment to revolutionizing organ preservation in China.
Recent developments in the China Organ Preservation Market highlight significant advancements and collaborations among key players. In June 2023, United Therapeutics Corporation announced a strategic partnership with Beijing Shijitan Hospital to enhance organ preservation processes, aiming to improve organ viability for transplantation.
Research initiatives have ramped up at Xi'an Jiaotong University as they unveiled a new cryopreservation technology that holds promise for better organ recovery rates. Additionally, Wuxi Apptec has expanded its capabilities to provide enhanced logistic solutions for organ transportation, integrating innovative preservation techniques to better serve hospitals nationwide.
Jiangsu University and Zhejiang University continue to contribute through collaborative Research and Development efforts focusing on long-term organ storage methodologies. Notably, there have been discussions surrounding mergers; however, as of October 2023, no substantial acquisition activity has been publicly disclosed within the specific companies of interest.
Overall, the market is witnessing a surge in technological advancements and academic collaborations, strengthening the foundation for future growth in organ preservation techniques across China.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 19.28(USD Million) |
| MARKET SIZE 2024 | 20.4(USD Million) |
| MARKET SIZE 2035 | 37.2(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.613% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Sinopharm, United Therapeutics Corporation, Jiangsu University, Beijing Shijitan Hospital, Xi'an Jiaotong University, Shanghai Shyndec Pharmaceutical, Wuxi Apptec, Nantong University, Zhejiang University, Tianjin Tsinghua University Technology, Peking Union Medical College, Guangzhou Medical University, Huazhong University of Science and Technology, Fujian Medical University |
| SEGMENTS COVERED | Solution, Preservation Techniques, Organ Type, End User |
| KEY MARKET OPPORTUNITIES | Increasing organ transplant demand, Advanced preservation technologies, Growing aging population, Rising healthcare investments, Expanding public awareness programs |
| KEY MARKET DYNAMICS | increasing transplant demand, technological advancements, regulatory changes, rising healthcare expenditures, growing awareness and acceptance |
| COUNTRIES COVERED | China |
Frequently Asked Questions (FAQ) :
The China Organ Preservation Market is expected to reach a valuation of 37.2 USD million by the year 2035.
In 2024, the China Organ Preservation Market is valued at 20.4 USD million.
The expected CAGR for the China Organ Preservation Market during the forecast period from 2025 to 2035 is 5.613%.
The University of Wisconsin Solution segment is expected to dominate the market, projected to reach 13.2 USD million by 2035.
The Custodial HTK solution is expected to have a valuation of 5.4 USD million in 2024.
Key players in the market include Sinopharm, United Therapeutics Corporation, Jiangsu University, and several universities and hospitals.
The Collins Solution is valued at 4.0 USD million in 2024 within the China Organ Preservation Market.
The growing demand for organ transplants and advancements in preservation techniques present significant growth opportunities.
The Celsior Solution is expected to grow to a valuation of 5.0 USD million by 2035.
Challenges include competition among leading solutions and the need for regulatory compliance in organ transplantation.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
